Current Opinion in Immunology

Article	Citations
Gene: environment interactions in immune and inflammatory responses to severe acute respiratory syndrome coronavirus 2 infection	425
TAP-ing into the cross-presentation secrets of dendritic cells	109
Oncogenic viruses, cancer biology, and innate immunity	106
AP-1 transcription factors in cytotoxic lymphocyte development and antitumor immunity	91
Mechanistic insights into epigenetic contributions to psoriasis pathogenesis and their clinical implications	83
Inflammasome activation by SARS-CoV-2 and its participation in COVID-19 exacerbation	70
An easy pill to swallow: oral recombinant vaccines for the 21st century	63
Can juvenile idiopathic arthritis be cured?	63
Principles and practical applications of structure-based vaccine design	59
T cells in Sjögren’s disease: update on their role in salivary gland pathogenesis and treatment	58
The future of vaccination in Latin America: learning from the COVID-19 pandemic	57
B cell–targeted therapies in autoimmune skin disease: current advances and challenges	56
Complement in antiphospholipid syndrome, time to target?	55
Nutritional modulation of antitumor immunity	55
Metabolism and macrophages in the tumor microenvironment	54
Neuropsychiatric lupus: a myriad of symptoms requires a myriad of models	51
Regulation of MHC class II and CD86 expression by March-I in immunity and disease	46
Can sarcoidosis be cured?	46
Commander-in-chief: monocytes rally the troops for defense against aspergillosis	39
Some thoughts about what non-mammalian jawed vertebrates are telling us about antigen processing and peptide loading of MHC molecules	33
Innate antiviral immunity and immunometabolism in hepatocytes	33
Pharmacotherapeutic strategies to promote regulatory T cell function in autoimmunity	31
Beyond the gastric epithelium — the paradox of Helicobacter pylori-induced immune responses	31
The epidermal immune microenvironment plays a central role in the pathogenesis of psoriasis	31
Can we cure Behçet syndrome?	31

Necroptosis in immunity, tissue homeostasis, and cancer	31
Mapping and modelling human B cell maturation in the germinal centre	29
Immunological scars after cure of hepatitis C virus infection: Long‐HepC?	29
Can we cure bullous skin diseases?	28
Patterns of bacterial viability governing noncanonical inflammasome activation	28
Mechanistic considerations linking SARS-CoV-2 infection, inflammation, and the loss of immune tolerance	27
The power of genetics in decoding Sjögren’s disease: current status and future development	27
Animal models of autoimmune encephalitis	27
Implication of epigenetic factors in development and recurrence of psoriasis	27
Bioinspired vaccines to enhance MHC class-I antigen cross-presentation	26
Editorial Board	26
Outer membrane vesicle-based intranasal vaccines	25
Editorial Board	25
Resolving adjuvant mode of action to enhance vaccine efficacy	24
Thetis cells: regulators of intestinal immune tolerance	24
Game of Omes: ribosome profiling expands the MHC-I immunopeptidome	23
Immune responses to Toxoplasma gondii	23
Can we cure antiphospholipid syndrome?	23
Nucleic acid triggers of autoimmunity and autoinflammation	22
The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention	21
Harnessing IgG Fc glycosylation for clinical benefit	21
Treating sarcoidosis: when less is more	20
A throwback on 25 years in pannexin research	20
Powerful microscopy technologies decode spatially organized cellular networks that drive response to immunotherapy in humans	20
HLA-B27 as a potential target for the cure of axial spondyloarthritis	20
New insights into the mechanisms regulating plasma cell survival and longevity	20
New autoantibodies in Sjögren's disease	20
Killing in self-defense: proapoptotic drugs to eliminate intracellular pathogens	19
Editorial Board	19
Editorial Board	19
Epigenetics: the link between environmental exposures and autoimmune diseases	19
Neuroimmune crosstalk in the skin: a delicate balance governing inflammatory processes	18
Intracellular complement in monocytes and macrophages: emerging roles	17
Rheumatoid arthritis — the role of T cells in this complex systemic autoimmune disease	17
Can we cure lupus?	17
Inborn errors of human transcription factors governing IFN-γ antimycobacterial immunity	17
‘Can we cure IgG4-related diseases?’	17
Metabolomic signaling in sarcoidosis pathogenesis	17
B cell memory of Immunoglobulin E (IgE) antibody responses in allergy	17
Drivers and shapers of macrophages specification in the developing brain	17
Regulation of type I and type III interferon induction in response to pathogen sensing	16
Multiple sclerosis: a disease or a syndrome?	16
Tumor immune evasion through loss of MHC class-I antigen presentation	16
Regulation of inflammation by Interleukin-10 in the intestinal and respiratory mucosa	16
A critical look at animal and cellular models in autoinflammatory diseases	16
Molecular mechanisms of tumour necrosis factor signalling via TNF receptor 1 and TNF receptor 2 in the tumour microenvironment	16
Mechanisms and risk factors for perinatal allergic disease	16
Autoimmunity, epitope analysis, and molecular mimicry	15
Red blood cell alloimmunization immunogenetic risk factor	15
Advances and challenges in investigating B-cells via single-cell transcriptomics	15

IFNε, IFNω and IFNλ: interferons defending the mucosa	15
The role of epigenetic modifications in systemic autoinflammatory diseases	15
Eliciting or silencing complement activation: strategies for optimizing monoclonal antibodies functions	15
Immunometabolic regulation of germinal centers and its implications for aging	14
Composite and pragmatic measures in psoriatic arthritis: bridging trials and clinical feasibility	14
Major histocompatibility complex class II in the tumor microenvironment: functions of nonprofessional antigen-presenting cells	14
PANoptosome signaling and therapeutic implications in infection: central role for ZBP1 to activate the inflammasome and PANoptosis	14
Challenges in diagnosis of sarcoidosis	14
TH17 cell immune adaptation	14
The role of epigenetics in inflammatory memory	14
Layers of defense: protection from respiratory viruses by epithelial-intrinsic immunity	14
Functional flexibility and plasticity in immune control of systemic Salmonella infection	14
New insights and approaches for analyses of immunopeptidomes	14
Defining the niche for stem-like CD8+ T cell formation and function	14
HyperIgE in hypomorphic recombination-activating gene defects	14
Addressing unmet needs in rheumatoid arthritis: the challenge of translating multi-omics into precision therapies	13
The choroid plexus in inflammatory and degenerative diseases of the central nervous system	13
Editorial overview: Tumour immunology: Engineered T cell therapy of cancer: current success and future improvements	13
Differential signaling by type-I and type-III interferons in mucosa	13
Curing inflammatory bowel diseases: breaking the barriers of current therapies– emerging strategies for a definitive treatment	13
Inherited human ZNF341 deficiency	13
The thymoproteasome in shaping the CD8+ T-cell repertoire	13
T follicular helper cells in food allergy	12
Harnessing microglia-based cell therapies for the treatment of neurodegenerative diseases	12
Human inborn errors of type I interferon–independent intrinsic immunity in nonleukocytic cells	12
The role of intestinal bacteria in promoting tolerance to food	12
Editorial Board	12
Harnessing dendritic cell diversity in cancer immunotherapy	12
Editorial overview: Special section neuroimmunology: Neuroimmune interactions in health and disease	12
Inflammation induced by lipid mediators and protein from transfusion products	12
Molecular insights into metabolite antigen recognition by mucosal-associated invariant T cells	11
Inflammasomes and their role in PANoptosomes	11
Microbiota and B-1 B cell repertoire development in mice	11
Local complement inhibition by selective precision-targeted therapies	11
Mpox virus immunology: exploring links to autoimmune diseases	11
Pulmonary transfusion reactions as an immunological spectrum disorder	10
Spontaneous and induced adaptive immune responses in Alzheimer’s disease: new insights into old observations	10
Extracellular vesicle impact on immunity following blood transfusion	10
Microevolution of Pseudomonas aeruginosa in the airways of people with cystic fibrosis	10
Potential immune consequences of cold-stored platelet transfusion	10
The vicious cycle governing the brain–immune system relationship in neurodegenerative diseases	10
B-cell antigen presentation in central nervous system autoimmunity	10
From metabolomics to transfusion-associated immunomodulation	10
The tumor-driven antibody-mediated immune response in cancer	10
Spatiotemporal and cell-state control of antigen presentation during tolerance and immunity	10
Mapping the B-cell axis in Sjögren’s disease: repertoire, microenvironment, and potential routes to precision treatment	10
Emerging novel therapies for steroid-refractory acute graft-versus-host disease: recent advances and future directions	9
Elderly-onset rheumatoid arthritis as a distinct entity: mechanisms, manifestations, and treatment	9
Multilevel approaches to immunization equity	9
Neuroimmune mechanisms of neuropsychiatric systemic lupus erythematosus	9
Can we cure Sjogren’s disease? Unmet needs and raising questions in the era of Precision medicine	9
Human guanylate-binding proteins in intracellular pathogen detection, destruction, and host cell death induction	9
In search of the cell biology for self- versus non-self- recognition	9
Autoimmune-related adverse events induced by immune checkpoint inhibitors	9
The role of the antigen processing machinery in the regulation and trafficking of intracellular -Toll-like receptor molecules	9
Editorial Board	9
Friends close, enemies closer: the complex role of the microbiome in antitumor immunity	9
Immunotherapy for pemphigus and bullous pemphigoid	9
Editorial Board	9
Toward indole postbiotics precision therapy via AI-powered drug delivery technologies	9
Editorial overview: Getting the house in order: Cell-intrinsic mechanisms of innate immune defence	9
The role of linked recognition and B cell precursor frequency in alloimmunization to transfused RBCs	8
B cells spatial organization defines their phenotype and function in cancer “Tell me with whom you consort, and I will tell you who you are” ― Goethe	8
T cell immunity to cytomegalovirus infection	8
Antiviral responses in peripheral and brain neurons	8
The next frontier in vaccine design: blending immune correlates of protection into rational vaccine design	8
Fuelling B cells: dynamic regulation of B cell metabolism	8
Major histocompatibility complex class I assembly within endolysosomal pathways	8
Chemokines that govern T cell activity in tumors	8
The indole-brain connection: neuroimmune mechanisms and therapy	8
SARS-CoV-2 and chronic kidney disease: challenges and future directions	8
Structure–function of type I and III interferons	8
Advances in treatment of psoriatic arthritis: current guidelines and emerging therapies	8
TRPM7 channel-kinase in immunity: new frontiers of an emerging therapeutic target	8
Editorial Board	7
The role of interferon in the thymus	7
Two for the price of one: itaconate and its derivatives as an anti-infective and anti-inflammatory immunometabolite	7
Editorial Board	7
Peptide-dependent tuning of major histocompatibility complex motional properties and the consequences for cellular immunity	7
Insights into the pathogenesis of allergic disease from dedicator of cytokinesis 8 deficiency	7

Insights into pandemic respiratory viruses: manipulation of the antiviral interferon response by SARS-CoV-2 and influenza A virus	7
Patterns and trends in sarcoidosis: an epidemiological perspective	7
Moving beyond the Janus kinase signaling kinases in the pathogenesis and treatment of psoriasis and psoriatic arthritis	7
Carbohydrate metabolism in supporting and regulating neutrophil effector functions	7
Turning foes into permissive hosts: manipulation of macrophage polarization by intracellular bacteria	7
Dupilumab-associated lymphoproliferative disorders: a comprehensive review on clinicohistopathologic features and underlying mechanisms	6
Cell entry and innate sensing shape adaptive immune responses to adenovirus-based vaccines	6
Immunological insights in the treatment of chronic hepatitis B	6
The role of stromal cell immunobiology in understanding and managing Sjögren’s disease	6
Regulatory T cells in the context: deciphering the dynamic interplay with the tissue environment	6
Developments in oral enterotoxigenic Escherichia coli vaccines	6
Tissue-specific proteasomes in generation of MHC class I peptides and CD8+ T cells	6
T-bethighCD21low B cells: the need to unify our understanding of a distinct B cell population in health and disease	6
Nr4a nuclear receptors: markers and modulators of antigen receptor signaling	6
Metabolic adaptations of ILC2 and Th2 cells in type 2 immunity	6
Minor salivary gland biopsy in Sjogren’s disease: a diagnostic and prognostic tool toward precision medicine	6
The role of allergen-specific regulatory T cells in the control of allergic disease	6
Optimizing patient-reported outcomes for sarcoidosis	6
Move and countermove: the integrated stress response in picorna- and coronavirus-infected cells	6
Epithelial-immune interactions govern type 2 immunity at barrier surfaces	5
T cell–B cell interactions in human autoimmune diseases	5
Metabolic footprint and logic through the T cell life cycle	5
From genes to granulomas: the genetic blueprint of sarcoidosis	5
Editorial overview: Innate immunity – 2023: Just in time defense	5
Messenger ribonucleic acid vaccines against infectious diseases: current concepts and future prospects	5
Tipping the balance: innate and adaptive immunity in mitochondrial disease	5
Advances in genetic–immunological targeted therapies for psoriasis	5
Evolution and prospects for the definition of clinically useful endpoints in Sjögren disease	5
Insights into platelet post-transfusional human leukocyte antigen I immunization	5
Tripping the wire: sensing of viral protease activity by CARD8 and NLRP1 inflammasomes	5
Editorial overview: Autoimmunity 2022	5
Editorial Board	5
C1 inhibitor: from complement system to bradykinin angioedema	5
Determinants of persistent Salmonella infections	5
Lymphatic messengers: Non-antigen soluble mediators from diseased tissues to draining lymph nodes	5
Salivary gland organoids and the future of modeling autoimmune epithelitis in Sjögren’s disease	5
Systems biology approaches to unravel lymphocyte subsets and function	5
Imaging the T-cell receptor: new approaches, new insights	4
Functional subsets of tumor-specific CD8+ T cells in draining lymph nodes and tumor microenvironment	4
More X’s, more problems: how contributions from the X chromosomes enhance female predisposition for autoimmunity	4
Immunological complications of blood transfusion: current insights and advances	4
CD1 displays its own negative regulators	4
Diet-derived microbial metabolites as regulators of immune function	4
The antiviral state of the cell: lessons from SARS-CoV-2	4
Markers predicting lymphoma development in Sjögren disease: current status and future perspectives	4
Mitochondrial reactive oxygen species: double agents in Mycobacterium tuberculosis infection	4
Tissue-resident CD8 T cells in central nervous system inflammatory diseases: present at the crime scene and …guilty	4
Mapping economic outcomes: how biosimilars enhance access to health systems in Latin America and the Caribbean	4
Recent progress in understanding of allergic transfusion reaction	4
Recent progress in type 1 classical dendritic cell cross-presentation - cytosolic, vacuolar, or both?	4
The immunometabolic roots of aging	4
Viral vector vaccines	4
Help me help you: emerging concepts in T follicular helper cell differentiation, identity, and function	4
Neuroimmune recognition of allergens	4
Nasal vaccines for pertussis	4
Principles of bacterial innate immunity against viruses	4